Janus Henderson Group PLC Avidity Biosciences, Inc. Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
A detailed history of Janus Henderson Group PLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 10,777,317 shares of RNA stock, worth $476 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
10,777,317
Previous 11,426,696
5.68%
Holding current value
$476 Million
Previous $337 Million
9.26%
% of portfolio
0.16%
Previous 0.19%
Shares
13 transactions
Others Institutions Holding RNA
# of Institutions
232Shares Held
119MCall Options Held
340KPut Options Held
145K-
Price T Rowe Associates Inc Baltimore, MD10.8MShares$478 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY9.62MShares$425 Million4.2% of portfolio
-
Wellington Management Group LLP Boston, MA9.25MShares$409 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.25MShares$409 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$381 Million0.01% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $2.3B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...